Karyopharm Therapeutics, Inc. (KPTI)

8.77 +0.46 (+5.54%) USD  |  NASDAQ  |  May 01, 16:00
8.77 0.00 (0.00%) After-Hours: 20:00
More

Karyopharm Therapeutics Price to CFO Per Share (TTM)

Price to CFO Per Share (TTM) Chart

View Price to CFO Per Share (TTM) for KPTI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to CFO Per Share (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to CFO Per Share (TTM) Range, Past 5 Years

View Price to CFO Per Share (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to CFO Per Share (TTM) Benchmarks

View Price to CFO Per Share (TTM) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. --
Agios Pharmaceuticals, Inc. --